Related references
Note: Only part of the references are listed.Temporal Profile of Matrix Metalloproteinases and Their Inhibitors in a Human Endothelial Cell Culture Model of Cerebral Ischemia
Bjoern Reuter et al.
CEREBROVASCULAR DISEASES (2013)
Statin Therapy and Outcome After Ischemic Stroke Systematic Review and Meta-Analysis of Observational Studies and Randomized Trials
Danielle Ni Chroinin et al.
STROKE (2013)
Statin Use During Ischemic Stroke Hospitalization Is Strongly Associated With Improved Poststroke Survival
Alexander C. Flint et al.
STROKE (2012)
Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells
Tatiane C. Izidoro-Toledo et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2011)
Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability
Marika Massaro et al.
CARDIOVASCULAR RESEARCH (2010)
Statin Treatment and Stroke Outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial
Larry B. Goldstein et al.
STROKE (2009)
Markers of instability in high-risk carotid plaques are reduced by statins
Hagen Kunte et al.
JOURNAL OF VASCULAR SURGERY (2008)
Multiple roles for MMPs and TIMPs in cerebral ischemia
LA Cunningham et al.
GLIA (2005)
Matrix metalloproteinases in cerebrovascular diseases
M Fatar et al.
CEREBROVASCULAR DISEASES (2005)
Statins inhibit secretion of metalloproteinases-1,-2,-3, and-9 from vascular smooth muscle cells and macrophages
ZX Luan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Share Paper
